Tag: BALT

Cerus Endovascular and Balt enter strategic distribution agreement for devices treating...

Cerus Endovascular and AB Medica, a subsidiary of Balt, has announced that they have entered into a strategic distribution agreement providing AB Medica with...
Squid trial embolisation balt

Balt receives CE mark for its Silk Vista flow diverter

Balt has received CE mark approval for its Silk Vista flow diverting stent to treat patients with unruptured intracranial aneurysms, in turn enabling commercialisation...
Squid trial embolisation balt

Balt receives IDE approval to begin the STEM trial

Balt has received investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) to begin the Squid trial for the embolisation of the middle meningeal...
Squid trial embolisation balt

Balt USA announces CE mark obtained for Titan aspiration catheter

Balt USA has announced that it has obtained CE mark for the Titan aspiration catheter. The Titan catheter line consists of a highly navigable,...

Balt announces receiving CE mark for Magic Glue, a next generation...

Balt International has announced receiving the CE mark for Magic Glue, its next generation of cyanoacrylate liquid embolic agent. Magic Glue is indicated for...

BALT International acquires Blockade Medical

BALT International has announced that it has acquired Blockade Medical LLC, a privately held company focused on the development of catheter based therapeutic devices...